Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Apply
Asciminib & TKI
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step